Limited coverage drugs – goserelin
Last updated on August 27, 2024
|
Generic name / Strength / Form |
|---|
|
goserelin |
|
Special Authority criteria |
Approval period |
|---|---|
| Diagnosis of endometriosis | First approval: 6 months
Renewal: 6 months |
Practitioner exemptions
- None
Special notes
- For any cancer-related condition, please contact the British Columbia Cancer Agency at (604) 877-6098 ext. 4610.